Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study

Infantile hemangioma (IH), the most common benign tumor in infancy, mostly arises and has rapid growth before 3 months of age. Because irreversible skin changes occur in the early proliferative stage, early medical treatment is essential to reduce the permanent sequelae caused by IH. Yet there are s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of proteome research 2022-03, Vol.21 (3), p.822-832
Hauptverfasser: Jiang, Cheng-Hong, Lin, Peng-Fei, Chen, Fa-Chun, Chen, Jia-Yao, Xie, Wen-Jun, Li, Ming, Hu, Xiao-Jie, Chen, Wen-Lian, Cheng, Yu, Lin, Xiao-xi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 832
container_issue 3
container_start_page 822
container_title Journal of proteome research
container_volume 21
creator Jiang, Cheng-Hong
Lin, Peng-Fei
Chen, Fa-Chun
Chen, Jia-Yao
Xie, Wen-Jun
Li, Ming
Hu, Xiao-Jie
Chen, Wen-Lian
Cheng, Yu
Lin, Xiao-xi
description Infantile hemangioma (IH), the most common benign tumor in infancy, mostly arises and has rapid growth before 3 months of age. Because irreversible skin changes occur in the early proliferative stage, early medical treatment is essential to reduce the permanent sequelae caused by IH. Yet there are still no early screening biomarkers for IH before its visible emergence. This study aimed to explore prediction biomarkers using noninvasive umbilical cord blood (UCB). A prospective study of the metabolic profiling approach was performed on UCB sera from 28 infants with IH and 132 matched healthy controls from a UCB population comprising over 1500 infants (PeptideAtlas: PASS01675) using liquid chromatography–mass spectrometry. The metabolic profiling results exhibited the characteristic metabolic aberrance of IH. Machine learning suggested a panel of biomarkers to predict the occurrence of IH, with the area under curve (AUC) values in the receiver operating characteristic analysis all >0.943. Phenylacetic acid had potential to predict infants with large IH (diameter >2 cm) from those with small IH (diameter
doi_str_mv 10.1021/acs.jproteome.1c00430
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2555973063</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2555973063</sourcerecordid><originalsourceid>FETCH-LOGICAL-a351t-45111a716dcf802e354b3c0aab3a4851d5ac5ce4c8b7f1abf9d2c4095d084eb23</originalsourceid><addsrcrecordid>eNqFkEFP4zAQhS0EWqC7PwHkI5cWTxyThBtUsCAVsVqWczSxJ8jgxMVOKnHgv69LC1dOY43fezPzMXYEYgYig1PUcfa8DH4g39EMtBC5FDvsAJRUU1mJYvfzXVZynx3G-CwEqELIH2xf5hIqEOUBe7-jARvvrOZ_gm-ts_0T_0srQkcmtchYPVjf80vrOwwvFCJvfeC3fYv9YB3xG-qwf1r_ctvzx65JGRodn_tg-KXz3vAHCnjOL9YT4pJS3or4wzCat59sr0UX6de2Ttjj9dW_-c10cf_7dn6xmKJUMExzBQBYwJnRbSkykipvpBaIjcS8VGAUaqUp12VTtIBNW5lM56JSRpQ5NZmcsJNNbgL2OlIc6s5GTc5hT36MdaaUqgopzmSSqo1Up2VjoLZeBpsuf6tB1GvydSJff5Gvt-ST73g7Ymw6Ml-uT9RJABvBh9-PoU8XfxP6H9EhlcA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2555973063</pqid></control><display><type>article</type><title>Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study</title><source>ACS Publications</source><creator>Jiang, Cheng-Hong ; Lin, Peng-Fei ; Chen, Fa-Chun ; Chen, Jia-Yao ; Xie, Wen-Jun ; Li, Ming ; Hu, Xiao-Jie ; Chen, Wen-Lian ; Cheng, Yu ; Lin, Xiao-xi</creator><creatorcontrib>Jiang, Cheng-Hong ; Lin, Peng-Fei ; Chen, Fa-Chun ; Chen, Jia-Yao ; Xie, Wen-Jun ; Li, Ming ; Hu, Xiao-Jie ; Chen, Wen-Lian ; Cheng, Yu ; Lin, Xiao-xi</creatorcontrib><description>Infantile hemangioma (IH), the most common benign tumor in infancy, mostly arises and has rapid growth before 3 months of age. Because irreversible skin changes occur in the early proliferative stage, early medical treatment is essential to reduce the permanent sequelae caused by IH. Yet there are still no early screening biomarkers for IH before its visible emergence. This study aimed to explore prediction biomarkers using noninvasive umbilical cord blood (UCB). A prospective study of the metabolic profiling approach was performed on UCB sera from 28 infants with IH and 132 matched healthy controls from a UCB population comprising over 1500 infants (PeptideAtlas: PASS01675) using liquid chromatography–mass spectrometry. The metabolic profiling results exhibited the characteristic metabolic aberrance of IH. Machine learning suggested a panel of biomarkers to predict the occurrence of IH, with the area under curve (AUC) values in the receiver operating characteristic analysis all &gt;0.943. Phenylacetic acid had potential to predict infants with large IH (diameter &gt;2 cm) from those with small IH (diameter &lt;2 cm), with an AUC of 0.756. The novel biomarkers in noninvasive UCB sera for predicting IH before its emergence might lead to a revolutionary clinical utility.</description><identifier>ISSN: 1535-3893</identifier><identifier>EISSN: 1535-3907</identifier><identifier>DOI: 10.1021/acs.jproteome.1c00430</identifier><identifier>PMID: 34319108</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Journal of proteome research, 2022-03, Vol.21 (3), p.822-832</ispartof><rights>2021 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a351t-45111a716dcf802e354b3c0aab3a4851d5ac5ce4c8b7f1abf9d2c4095d084eb23</citedby><cites>FETCH-LOGICAL-a351t-45111a716dcf802e354b3c0aab3a4851d5ac5ce4c8b7f1abf9d2c4095d084eb23</cites><orcidid>0000-0003-3069-9046 ; 0000-0003-3388-5485</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.1c00430$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jproteome.1c00430$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34319108$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jiang, Cheng-Hong</creatorcontrib><creatorcontrib>Lin, Peng-Fei</creatorcontrib><creatorcontrib>Chen, Fa-Chun</creatorcontrib><creatorcontrib>Chen, Jia-Yao</creatorcontrib><creatorcontrib>Xie, Wen-Jun</creatorcontrib><creatorcontrib>Li, Ming</creatorcontrib><creatorcontrib>Hu, Xiao-Jie</creatorcontrib><creatorcontrib>Chen, Wen-Lian</creatorcontrib><creatorcontrib>Cheng, Yu</creatorcontrib><creatorcontrib>Lin, Xiao-xi</creatorcontrib><title>Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study</title><title>Journal of proteome research</title><addtitle>J. Proteome Res</addtitle><description>Infantile hemangioma (IH), the most common benign tumor in infancy, mostly arises and has rapid growth before 3 months of age. Because irreversible skin changes occur in the early proliferative stage, early medical treatment is essential to reduce the permanent sequelae caused by IH. Yet there are still no early screening biomarkers for IH before its visible emergence. This study aimed to explore prediction biomarkers using noninvasive umbilical cord blood (UCB). A prospective study of the metabolic profiling approach was performed on UCB sera from 28 infants with IH and 132 matched healthy controls from a UCB population comprising over 1500 infants (PeptideAtlas: PASS01675) using liquid chromatography–mass spectrometry. The metabolic profiling results exhibited the characteristic metabolic aberrance of IH. Machine learning suggested a panel of biomarkers to predict the occurrence of IH, with the area under curve (AUC) values in the receiver operating characteristic analysis all &gt;0.943. Phenylacetic acid had potential to predict infants with large IH (diameter &gt;2 cm) from those with small IH (diameter &lt;2 cm), with an AUC of 0.756. The novel biomarkers in noninvasive UCB sera for predicting IH before its emergence might lead to a revolutionary clinical utility.</description><issn>1535-3893</issn><issn>1535-3907</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkEFP4zAQhS0EWqC7PwHkI5cWTxyThBtUsCAVsVqWczSxJ8jgxMVOKnHgv69LC1dOY43fezPzMXYEYgYig1PUcfa8DH4g39EMtBC5FDvsAJRUU1mJYvfzXVZynx3G-CwEqELIH2xf5hIqEOUBe7-jARvvrOZ_gm-ts_0T_0srQkcmtchYPVjf80vrOwwvFCJvfeC3fYv9YB3xG-qwf1r_ctvzx65JGRodn_tg-KXz3vAHCnjOL9YT4pJS3or4wzCat59sr0UX6de2Ttjj9dW_-c10cf_7dn6xmKJUMExzBQBYwJnRbSkykipvpBaIjcS8VGAUaqUp12VTtIBNW5lM56JSRpQ5NZmcsJNNbgL2OlIc6s5GTc5hT36MdaaUqgopzmSSqo1Up2VjoLZeBpsuf6tB1GvydSJff5Gvt-ST73g7Ymw6Ml-uT9RJABvBh9-PoU8XfxP6H9EhlcA</recordid><startdate>20220304</startdate><enddate>20220304</enddate><creator>Jiang, Cheng-Hong</creator><creator>Lin, Peng-Fei</creator><creator>Chen, Fa-Chun</creator><creator>Chen, Jia-Yao</creator><creator>Xie, Wen-Jun</creator><creator>Li, Ming</creator><creator>Hu, Xiao-Jie</creator><creator>Chen, Wen-Lian</creator><creator>Cheng, Yu</creator><creator>Lin, Xiao-xi</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3069-9046</orcidid><orcidid>https://orcid.org/0000-0003-3388-5485</orcidid></search><sort><creationdate>20220304</creationdate><title>Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study</title><author>Jiang, Cheng-Hong ; Lin, Peng-Fei ; Chen, Fa-Chun ; Chen, Jia-Yao ; Xie, Wen-Jun ; Li, Ming ; Hu, Xiao-Jie ; Chen, Wen-Lian ; Cheng, Yu ; Lin, Xiao-xi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a351t-45111a716dcf802e354b3c0aab3a4851d5ac5ce4c8b7f1abf9d2c4095d084eb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jiang, Cheng-Hong</creatorcontrib><creatorcontrib>Lin, Peng-Fei</creatorcontrib><creatorcontrib>Chen, Fa-Chun</creatorcontrib><creatorcontrib>Chen, Jia-Yao</creatorcontrib><creatorcontrib>Xie, Wen-Jun</creatorcontrib><creatorcontrib>Li, Ming</creatorcontrib><creatorcontrib>Hu, Xiao-Jie</creatorcontrib><creatorcontrib>Chen, Wen-Lian</creatorcontrib><creatorcontrib>Cheng, Yu</creatorcontrib><creatorcontrib>Lin, Xiao-xi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of proteome research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jiang, Cheng-Hong</au><au>Lin, Peng-Fei</au><au>Chen, Fa-Chun</au><au>Chen, Jia-Yao</au><au>Xie, Wen-Jun</au><au>Li, Ming</au><au>Hu, Xiao-Jie</au><au>Chen, Wen-Lian</au><au>Cheng, Yu</au><au>Lin, Xiao-xi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study</atitle><jtitle>Journal of proteome research</jtitle><addtitle>J. Proteome Res</addtitle><date>2022-03-04</date><risdate>2022</risdate><volume>21</volume><issue>3</issue><spage>822</spage><epage>832</epage><pages>822-832</pages><issn>1535-3893</issn><eissn>1535-3907</eissn><abstract>Infantile hemangioma (IH), the most common benign tumor in infancy, mostly arises and has rapid growth before 3 months of age. Because irreversible skin changes occur in the early proliferative stage, early medical treatment is essential to reduce the permanent sequelae caused by IH. Yet there are still no early screening biomarkers for IH before its visible emergence. This study aimed to explore prediction biomarkers using noninvasive umbilical cord blood (UCB). A prospective study of the metabolic profiling approach was performed on UCB sera from 28 infants with IH and 132 matched healthy controls from a UCB population comprising over 1500 infants (PeptideAtlas: PASS01675) using liquid chromatography–mass spectrometry. The metabolic profiling results exhibited the characteristic metabolic aberrance of IH. Machine learning suggested a panel of biomarkers to predict the occurrence of IH, with the area under curve (AUC) values in the receiver operating characteristic analysis all &gt;0.943. Phenylacetic acid had potential to predict infants with large IH (diameter &gt;2 cm) from those with small IH (diameter &lt;2 cm), with an AUC of 0.756. The novel biomarkers in noninvasive UCB sera for predicting IH before its emergence might lead to a revolutionary clinical utility.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>34319108</pmid><doi>10.1021/acs.jproteome.1c00430</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-3069-9046</orcidid><orcidid>https://orcid.org/0000-0003-3388-5485</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1535-3893
ispartof Journal of proteome research, 2022-03, Vol.21 (3), p.822-832
issn 1535-3893
1535-3907
language eng
recordid cdi_proquest_miscellaneous_2555973063
source ACS Publications
title Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A04%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20Profiling%20Revealed%20Prediction%20Biomarkers%20for%20Infantile%20Hemangioma%20in%20Umbilical%20Cord%20Blood%20Sera:%20A%20Prospective%20Study&rft.jtitle=Journal%20of%20proteome%20research&rft.au=Jiang,%20Cheng-Hong&rft.date=2022-03-04&rft.volume=21&rft.issue=3&rft.spage=822&rft.epage=832&rft.pages=822-832&rft.issn=1535-3893&rft.eissn=1535-3907&rft_id=info:doi/10.1021/acs.jproteome.1c00430&rft_dat=%3Cproquest_cross%3E2555973063%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2555973063&rft_id=info:pmid/34319108&rfr_iscdi=true